| Primary | Number of Participants Who Were a Success (Clear/Almost Clear) of Plaque Psoriasis at Week 4 Based on the Overall Disease Severity (ODS), Full Ordinal Scale From Baseline to Week 4 | Number of participants who were a success (Clear/Almost Clear) of Plaque Psoriasis at week 4 based on the Overall Disease Severity (ODS), full ordinal scale from baseline to week 4. Overall Disease Severity is evaluated on a scale from 0 - 4 (0 = Clear, 1 = Almost Clear, 2 = Mild, 3 = Moderate, 4 = Severe/Very Severe) with 0 being best and 4 being worst. | ITT (Intent to Treat), LOCF (Last Observation Carried Forward) | Posted | | Number | | participants | | Baseline to Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| | | Title | Denominators | Categories |
|---|
| | |
| |
| Secondary | Number of Participants Who Were a Success (Clear/Almost Clear) of Plaque Psoriasis at Week 2 Based on the Overall Disease Severity (ODS), Dichotomized Scale From Baseline to Week 2 | Number of participants who were a success (Clear/Almost Clear) of Plaque Psoriasis at Week 2 based on the Overall Disease Severity (ODS), dichotomized scale from Baseline to Week 2. Overall Disease Severity is evaluated on a scale from 0 - 4 (0 = Clear, 1 = Almost Clear, 2 = Mild, 3 = Moderate, 4 = Severe/Very Severe) with 0 being best and 4 being worst. | ITT (Intent to Treat), LOCF (Last Observation Carried Forward) | Posted | | Number | | participants | | Baseline to week 2 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Number of Participants in Each Category of the Global Assessment of Improvement (GAI) Scale From Baseline to Week 4 | Number of participants in each category of the Global Assessment of Improvement (GAI) Scale from Baseline to Week 4. The Global Assessment of Improvement is evaluated on a scale from -1 to 4 (-1 = Symptoms worse, 0 = No change, 1 = Minimal Improvement, 2 = Definite Improvement, 3 = Considerable Improvement and 4 = Clearing) with -1 being worst and 4 being best. | ITT (Intent to Treat); LOCF (Last Observation Carried Forward) | Posted | | Number | | participants | | Baseline to Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Number of Participants With a Decrease in Signs of Psoriasis (Erythema) Scores From Baseline to Week 4 | Number of participants with a decrease in Signs of Psoriasis (Erythema) scores from Baseline to Week 4. Signs of Psoriasis (Erythema) are evaluated on a scale from 0 - 4 (0 = Clear, 1 = Almost Clear, 2 = Mild, 3 = Moderate, 4 = Severe/Very Severe with 0 being best and 4 being worst. | ITT (Intent to Treat; LOCF (Last Observation Carried Forward) | Posted | | Number | | participants | | Baseline to Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Number of Participants With Decrease in Signs of Psoriasis (Scaling) Scores From Baseline to Week 4 | Number of participants with decrease in Signs of Psoriasis (Scaling) scores from Baseline to Week 4. Signs of Psoriasis (Scaling) are evaluated on a scale from 0 - 4 (0 = Clear, 1 = Almost Clear, 2 = Mild, 3 = Moderate, 4 = Severe/Very Severe) with 0 being best and 4 being worst. | ITT (Intent to Treat); LOCF (Last Observation Carried Forward) | Posted | | Number | | participants | | Baseline to Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Number of Participants With Decrease in Signs of Psoriasis (Plaque Elevation) Scores From Baseline to Week 4 | Number of participants with decrease in Signs of Psoriasis (Plaque Elevation) scores from Baseline to Week 4. Signs of Psoriasis (Plaque Elevation) are evaluated on a scale from 0 - 4 (0 = Clear, 1 = Almost Clear, 2 = Mild, 3 = Moderate, 4 = Severe/Very Severe) with 0 being best and 4 being worst. | ITT (Intent to Treat); LOCF (Last Observation Carried Forward) | Posted | | Number | | participants | | Baseline to Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Median Percent (%) Change From Baseline in % Treatable BSA (Body Surface Area) From Baseline to Week 4 | Median percent (%) change from baseline in % treatable BSA (Body Surface Area) from Baseline to Week 4 | ITT (Intent to Treat); LOCF (Last Observation Carried Forward) | Posted | | Median | Standard Deviation | Percent change | | Baseline to Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Mean Change From Baseline Scores for the Koo-Menter Psoriasis Index 12-item Quality of Life Questionnaire (PQOL-12) From Baseline to Week 4 | Mean change from baseline scores for the Koo-Menter Psoriasis Index 12-item Quality of Life Questionnaire (PQOL-12) from Baseline to Week 4. The Koo-Menter Psoriasis Index is a questionnaire with 12 questions that can be used to assess the effect that psoriasis has on a patient's overall quality of life. The questions are answered on a scale from 0 to 10 with 0 being best and 10 being worst. | | Posted | | Mean | Standard Deviation | Units on a scale | | Baseline to Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Number of Participants Who Responded to the Categories of Possible Answers to the Subject's Satisfaction Survey Question "The Treatment Program Was Easy to Follow" at Week 4 | Number of participants who responded to the categories of possible answers to the Subject's Satisfaction Survey question "The treatment program was easy to follow" at Week 4. Categories of possible answers include Strongly agree, Moderately agree, No opinion, Moderately disagree, and Strongly disagree. | | Posted | | Number | | participants | | Baseline and Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Number of Participants Who Responded to the Categories of Possible Answers to the Subject's Satisfaction Survey Question "I am Satisfied With my Appearance" at Week 4 | Number of participants who responded to the categories of possible answers to the Subject's Satisfaction Survey question "I am Satisfied with my Appearance" at Week 4. Categories of possible answers include Strongly agree, Moderately agree, No opinion, Moderately disagree, and Strongly disagree. | | Posted | | Number | | participants | | Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Number of Participants Who Responded to the Categories of Possible Answers to the Subject's Satisfaction Survey Question "I am Satisfied With the Results of This Treatment Program" at Week 4 | Number of participants who responded to the categories of possible answers to the Subject's Satisfaction Survey question "I am satisfied with the results of this treatment program" at Week 4. Categories of possible answers include Strongly agree, Moderately agree, No opinion, Moderately disagree, and Strongly disagree. | | Posted | | Number | | participants | | Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Number of Participants Who Responded to the Categories of Possible Answers to the Subject's Satisfaction Survey Question "I Would Use This Treatment Program Again if Recommended by the Dermatologist" at Week 4 | Number of participants who responded to the categories of possible answers to the Subject's Satisfaction Survey question "I would use this treatment program again if recommended by the dermatologist" at Week 4. Categories of possible answers include Strongly agree, Moderately agree, No opinion, Moderately disagree, and Strongly disagree. | | Posted | | Number | | participants | | Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |
| Secondary | Number of Participants With Tolerability Assessments Resulting in Adverse Events From Baseline to Week 4 | Number of participants with Tolerability Assessments resulting in Adverse Events from baseline to week 4. Tolerability assessments (Pruritus, telangiectasias, and stinging/burning) are evaluated on a scale from 0 - 3 (0 = None, 1 = Mild, 2 = Moderate, 3 = Severe) with 0 being best and 3 being worst. Skin atrophy and folliculitis are evaluated as absent or present. Changes in tolerability assessments that require a dose modification or concomitant medications/therapy are recorded as adverse events. | | Posted | | Number | | participants | | Baseline to Week 4 | | | | ID | Title | Description |
|---|
| OG000 | Vectical® Ointment (Weekdays) and Clobex® Spray (Weekends) | Vectical® Ointment, topical, apply twice daily on weekdays and Clobex® Spray, topical, apply twice daily on weekends for up to 28 days: Weekdays / Weekends Regimen | | OG001 | Clobex® Spray (Morning) and Vectical® Ointment (Evening) | Clobex® Spray, topical, apply once each morning and Vectical® Ointment, topical, apply once each evening for up to 28 days(PM): AM / PM Regimen |
| |